| Filed On | Filing |
|---|---|
| 07 May 2026 |
Form 3: Mulroy Dennis, Chief Financial Officer
No securities owned |
| 19 Dec 2025 |
Form 3: Roberts Joseph, Controller
Holds 2,001 shares of Common Stock |
| 21 Jun 2024 |
Form 3: Slaoui Moncef, Director
No securities owned |
| 13 Dec 2022 |
Form 3: Markels John, Director
No securities owned |
| 09 Dec 2021 |
Form 3: Marantz Jing L., Director
No securities owned |
| 10 Feb 2021 |
Form 3: Arcturus Therapeutics Holdings Inc., 10% owner · GRI Bio Inc
Holds 843,750 shares of Common Stock |
| 12 Aug 2020 |
Form 3: Kurata Lance, Chief Legal Officer
No securities owned |
| 20 Feb 2020 |
Form 3: Hughes Steven George, Chief Development Officer
No securities owned |
| 24 Sep 2019 |
Form 3: Holmes Edward W, Director
No securities owned |
| 26 Jun 2019 |
Form 3: Parschauer Karah Herdman, Director
No securities owned |
| 25 Jun 2019 |
Form 3: Ultragenyx Pharmaceutical Inc., Director
Holds 2,400,000 shares of Common Stock |
Loading...
